A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors
  • In the media
  • 荷兰公共卫生专家提醒：要警惕抗生素滥用
Media - published on 23 Jan 2020

荷兰公共卫生专家提醒：要警惕抗生素滥用

In this interview, Wang Qing from the Chinese business media outlet JieMian explores the importance of using antibiotics responsibly following the launch of the 2020 AMR Benchmark. 

During the 2020 WEF Annual Meeting, Wang Qing interviews Jay Iyer, Executive Director of the Access to Medicine Foundation, on the responsible use of antibiotics and antimicrobials, especially in view of the coronavirus outbreak in China. 

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |